PHS: PH:FB
Quotes are delayed by 20 min
Feb 1, 2023, 2:55 p.m.
₱
47.65
Change
+1.45 +3.14%
Volume
Volume 432,500
Quotes are delayed by 20 min
Previous close
₱ 46.20
₱ 47.65
Change
+1.45 +3.14%
Day low
Day high
₱46.25
₱47.75
52 week low
52 week high
₱34.10
₱70.20
Mr. Ramon S. Ang Vice Chairman, President & Chief Executive Officer |
Mr. Iidefonso B. Alindogan Vice President, Chief Financial & Strategy Officer |
Mr. Francisco S. Alejo Director & Chief Operating Officer-Food |
Ms. Alexandra Bengson-Trillana Secretary, General Counsel & Compliance Officer |
Mr. Oscar R. Sañez Vice President & Group Head-Corporate Affairs |
Mr. Roberto N. Huang Director & Chief Operating Officer-Beer |
Dr. Emmanuel B. Macalalag Director & Chief Operating Officer-Spirits |
Ms. Romela M. Bengzon Non-Executive Director |
Mr. Francis H. Jardeleza Director |
Mr. John Paul L. Ang Non-Executive Director |
Mr. Menardo R. Jimenez Non-Executive Director |
Mr. Ferdinand K. Constantino Treasurer & Director |
Ms. Aurora T. Calderon Non-Executive Director |
Ms. Kristina Lowella Garcia Assistant VP & Manager-Investor Relations |
Ms. Aurora S. Lagman Independent Director |
Mr. Ricardo C. Marquez Independent Non-Executive Director |
Mr. Cirilo P. Noel Independent Director |
Mr. Winston A. Chan Independent Director |
Altria Q4 revenue $6.111 bln, down 2.3%; FactSet consensus $5.148 bln
Peloton Q2 revenue down 23.4% to $616.5 mln, below the FactSet consensus $709.8 mln
AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance
A.O. Smith stock price target raised to $71 from $59 at Stifel Nicolaus
Atlas Technical Consultants downgraded to hold from buy at Stifel Nicolaus
General Mills started at neutral with $75 stock price target at Mizuho
AMD stock price target raised to $82 from $70 at J.P. Morgan
Boston Scientific stock slides 5% premarket after profit miss
Humana beats profit expectations but revenue comes up a bit shy
Boston Scientific now sees Q1 adj. EPS of 42 cents to 44 cents; FactSet consensus 44 cents
NIO, XPeng, and Li Auto Deliveries Struggle in January. The Stocks Rise Anyway.
Boston Scientific now sees full-year adj. EPS of $1.86 to $1.93; FactSet consensus $1.93
Virtual Stock Exchange